BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT02131064-completion@plaintrial.com
DTSTAMP:20261028T020753Z
DTSTART;VALUE=DATE:20180529
SUMMARY:A Study Evaluating Trastuzumab Emtansine Plus Pertuzumab Compared W
 ith Chemotherapy Plus Trastuzumab and Pertuzumab for Participants With Hum
 an Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer — es
 timated completion date
DESCRIPTION:Completed. Saved on your PlainTrial shortlist. Full trial recor
 d: https://plaintrial.com/trial/NCT02131064
URL:https://plaintrial.com/trial/NCT02131064
END:VEVENT
END:VCALENDAR
